Stemgent Obtains $11,299,993 New Round

  • Feed Type
  • Date
    8/13/2012
  • Company Name
    Stemgent
  • Mailing Address
    One Kendall Square B6201 Cambridge, MA 02139
  • Company Description
    Stemgent advances stem cell science by providing proprietary reagents and tools developed and proven for reproducibility by some of the world’s leading stem cell scientists.
  • Website
    http://www.stemgent.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $11,299,993
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.